Description
A synthetic bioactive sphingolipid; increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated in the nanoliposomal membrane of nanoliposomal-doxorubicin; induces proliferation and cytokine production by splenocytes in vitro (100-1,000 ng/ml); activates NF-κB production in C6 glioma cells (10 μM)
Formal name: N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-octanamide
Synonyms: Galactosylceramide (d18:1/8:0)|GalCer(d18:1/8:0)|N-octanoyl-β-D-Galactosylceramide
Molecular weight: 587.8
CAS: 41613-16-5
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer||Research Area|Cell Biology|Cell Signaling|NF-κB Signaling||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation||Research Area|Lipid Biochemistry|Sphingolipids